Literature DB >> 21760560

Circumventing the requirement of binding saturation for receptor quantification using interaction kinetic extrapolation.

Pavel Barta1, Hanna Björkelund, Karl Andersson.   

Abstract

Quantification of the number of receptors per cell (NRPC) is important when assessing whether a tumor surface biomarker is suitable for medical imaging. One common method for NPRC quantification is to use a binding saturation assay, which is time consuming and requires large amounts of reagents. The aim of this study was to evaluate an alternative method based on kinetic extrapolation (KEX) and compare it with the classical manual saturation technique with regard to accuracy as well as time and reagent consumption. Epidermal growth factor receptor (EGFR) and HER2 receptor surface expression were quantified on five tumor cell lines using three 125I-labeled and 131I-labeled ligands (cetuximab and EGF for EGFR, trastuzumab for HER2 receptor) for both techniques. The KEX method involved interaction measurements in the LigandTracer, followed by KEX through computerized real-time interaction analysis to correct for nonsaturation on cells. Variability and NRPC estimates of the EGFR and HER2 receptor levels using the KEX method were comparable with the results from the classical saturation technique. However, the ligand consumption for the KEX method was 26-46% of the classical saturation technique. Furthermore, the KEX method reduced the workload radically. From the observations described in this study, we believe that the KEX method enables fast, credible, and easy NRPC quantification with a reduction in reagent consumption.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21760560     DOI: 10.1097/MNM.0b013e3283483e1c

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  8 in total

1.  Quantification of interaction strengths between chaperones and tetratricopeptide repeat domain-containing membrane proteins.

Authors:  Regina Schweiger; Jürgen Soll; Kirsten Jung; Ralf Heermann; Serena Schwenkert
Journal:  J Biol Chem       Date:  2013-09-13       Impact factor: 5.157

2.  Gefitinib induces epidermal growth factor receptor dimers which alters the interaction characteristics with ¹²⁵I-EGF.

Authors:  Hanna Björkelund; Lars Gedda; Pavel Barta; Magnus Malmqvist; Karl Andersson
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

3.  Evaluating real-time immunohistochemistry on multiple tissue samples, multiple targets and multiple antibody labeling methods.

Authors:  Louise Dubois; Karl Andersson; Anna Asplund; Hanna Björkelund
Journal:  BMC Res Notes       Date:  2013-12-18

4.  Insights into the DNA-binding mechanism of a LytTR-type transcription regulator.

Authors:  Stefan Behr; Ralf Heermann; Kirsten Jung
Journal:  Biosci Rep       Date:  2016-04-27       Impact factor: 3.840

5.  High binding affinity of repressor IolR avoids costs of untimely induction of myo-inositol utilization by Salmonella Typhimurium.

Authors:  Jessica Hellinckx; Ralf Heermann; Angela Felsl; Thilo M Fuchs
Journal:  Sci Rep       Date:  2017-03-14       Impact factor: 4.379

6.  New approaches for the reliable in vitro assessment of binding affinity based on high-resolution real-time data acquisition of radioligand-receptor binding kinetics.

Authors:  Markus Zeilinger; Florian Pichler; Lukas Nics; Wolfgang Wadsak; Helmut Spreitzer; Marcus Hacker; Markus Mitterhauser
Journal:  EJNMMI Res       Date:  2017-03-07       Impact factor: 3.138

7.  Quantification of cell surface proteins with bispecific antibodies.

Authors:  C Panke; D Weininger; A Haas; F Schelter; T Schlothauer; S Bader; R Sircar; H P Josel; U Baer; H Burtscher; O Mundigl; M Grote; U Brinkmann; C Sustmann
Journal:  Protein Eng Des Sel       Date:  2013-08-19       Impact factor: 1.650

8.  KD determination from time-resolved experiments on live cells with LigandTracer and reconciliation with end-point flow cytometry measurements.

Authors:  Diana Spiegelberg; Jonas Stenberg; Pascale Richalet; Marc Vanhove
Journal:  Eur Biophys J       Date:  2021-07-24       Impact factor: 1.733

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.